Can New Antimalarials Be a Gamechanger in Endemic Countries?
JUN 16, 2017 | CONTAGION® EDITORIAL STAFF
Jeremy Burrows, DPhil, MA, Vice President, Head of Discovery, Medicines for Malaria Venture, Switzerland, explains how new antimalarials could change the game for countries where malaria is endemic.
Interview Transcript (slightly modified for readability)
“In the countries where malaria is endemic, these new treatment options are still incredibly important. First, because they will provide the treatment options of the future when the existing drugs fail because of resistance. Secondly, we have this ambition for elimination, eradication, and these new drugs, which are coming through the pipeline we hope will deliver the tools that will actually enable us to do that.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512